LDL Hypothesis Brings Out Skeptics, Supporters At FDA Panel
Agency told advisory committee weighing the IMPROVE-IT data not to debate the LDL-hypothesis; panelists did so anyway.
Agency told advisory committee weighing the IMPROVE-IT data not to debate the LDL-hypothesis; panelists did so anyway.